The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ARS PHARMACEUTICALS INC COM 82835W108   16,292,547 1,910,029 SH   SOLE   1,910,029 0 0
ARVINAS INC COM 04335A105   9,826,857 287,251 SH   SOLE   287,251 0 0
BLUEPRINT MEDICINES CORP COM 09627Y109   8,246,269 188,228 SH   SOLE   188,228 0 0
C4 THERAPEUTICS INC COM STK 12529R107   2,217,556 375,857 SH   SOLE   375,857 0 0
CULLINAN ONCOLOGY INC COM 230031106   12,883,080 1,221,145 SH   SOLE   1,221,145 0 0
EQRX INC COM 26886C107   32,236,883 13,104,424 SH   SOLE   13,104,424 0 0
KINNATE BIOPHARMA INC COM 49705R105   14,209,828 2,329,480 SH   SOLE   2,329,480 0 0
KRONOS BIO INC COM 50107A104   2,351,490 1,451,537 SH   SOLE   1,451,537 0 0
MIRATI THERAPEUTICS INC COM 60468T105   11,957,943 263,914 SH   SOLE   263,914 0 0
PMV PHARMACEUTICALS INC COM 69353Y103   12,056,521 1,385,807 SH   SOLE   1,385,807 0 0
RELAY THERAPEUTICS INC COM 75943R102   7,103,746 475,485 SH   SOLE   475,485 0 0
REVOLUTION MEDICINES INC COM 76155X100   99,794,581 4,189,529 SH   SOLE   4,189,529 0 0
THESEUS PHARMACEUTICALS INC COM 88369M101   3,044,324 611,310 SH   SOLE   611,310 0 0
TYRA BIOSCIENCES INC COM 90240B106   19,141,223 2,518,582 SH   SOLE   2,518,582 0 0